CoreRx, has completed its acquisition of Societal CDMO. CoreRx’s tender offer to acquire all of the issued and outstanding shares of common stock of Societal CDMO, at a purchase price of $1.10 per Share, in cash, without interest and less any applicable tax withholding, expired as scheduled one minute following 11:59 p.m., Eastern Time, on April 5, 2024 and was not further extended. The depositary and paying agent for the tender offer has advised CoreRx that, as of the expiration of the tender offer, a total of 102,588,622 Shares were validly tendered and not properly withdrawn, representing approximately 92.8% of the issued and outstanding Shares. Such Shares have been accepted for payment and will be promptly paid for in accordance with the terms of the tender offer. Following completion of the tender offer, CoreRx completed the acquisition of Societal CDMO through the previously planned second-step merger under Section 321(f) of the Pennsylvania Business Corporation Law of 1988. As a result of the merger, Societal CDMO became a wholly owned subsidiary of CoreRx. The common stock of Societal CDMO will be delisted from the Nasdaq Capital Market.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SCTL:
- Societal Cdmo at the Crossroads: Merger with CoreRx Faces Uncertain Future and Financial Risks
- Societal CDMO downgraded to Market Perform from Outperform at William Blair
- Societal CDMO downgraded to Equal Weight from Overweight at Stephens
- Societal CDMO downgraded to Sector Perform from Outperform at RBC Capital
- Societal CDMO’s Merger and Tender Offer by CoreRx